Canada Administers First Pfizer-BioNTech COVID Shot, Trudeau Says ‘Big Step’

3 min read | December 16, 2020 01:35 AM AEDT | By Team Kalkine Media

Summary

  • The first Pfizer-BioNTech COVID shot in Canada was reportedly administered to an 89-year-old woman from Quebec named Gisèle Lévesque.
  • Prime Minister Trudeau described the vaccination as a “big step”, but he stressed that the country is “not out of the woods yet”.
  • Canada is now the third country in the world to have administered the vaccine produced by Pfizer Inc (NYSE: PFE, PFE:US) and its German partner BioNTech SE (NASDAQ:BNTX).
  • Canada is scheduled to receive about 249,000 doses of the Pfizer vaccine by the end of December 2020, PM Trudeau announced earlier in the month.

COVID-19 inoculation campaign kick-started in Canada on Monday, December 14, after the first batch of the Pfizer-BioNTech vaccines reached the country on Sunday night.

The vaccination process was initiated with frontline health care workers and residents of elderly home care facilities, with the first shot reportedly being administered to an 89-year-old woman from Quebec named Gisèle Lévesque.

Prime Minister Justin Trudeau also tweeted a clip of a personal support worker from Toronto, named Anita Quidangen, receiving one of the first COVID-19 shots in the country. The video showed health care officials standing around Quidangen applauding as she received the injection.

Prime Minister Trudeau described the vaccination as a “big step”, but he stressed that the country is “not out of the woods yet”.

Canada is now the third country in the world to have administered the vaccine produced by Pfizer Inc (NYSE: PFE, PFE:US) and its German partner BioNTech SE (NASDAQ:BNTX).

 

Canada Scheduled To Receive About 249,000 Pfizer-BioNTech Vaccine Doses


Quebec's Health Minister Christian Dube reportedly said that about 150 residents of the province were in line to get the injection at Maimonides on Monday. He added that at least 50,000 Quebecers are expected to get vaccinated by January 4 next year.

©Kalkine Group Image

 

Prime Minister Trudeau broke the news of Canada receiving its first consignment of the Pfizer-BioNTech COVID-19 vaccines late on Sunday night. A shipment of about 30,000 doses reached Mirabel International Airport in Montreal, and was then sent forward to 14 distribution sites across Canada.

Canada is scheduled to receive about 249,000 doses of the Pfizer vaccine by the end of December 2020 and another shipment of three million doses by January next year, PM Trudeau announced earlier in December.

As of now, only people over the age of 16 are reportedly eligible for the Pfizer drug, while the clinical trials for children continue.

National health care regulator Health Canada is currently said to be reviewing COVID-19 vaccine candidates from three other pharmaceutical companies. So far, the Moderna Inc (NASDAQ: MRNA, MRNA: US) shot is showing most advanced results, as per reports.

The Canadian government has so far pre-ordered some 20 million doses from Pfizer Inc and BioNTech SE. As for its deals with all the pharmaceutical companies put together, Canada is reportedly in line to receive over 400 million doses of COVID-19 vaccines for its strength of about 38 million people.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.